期刊文献+

医院获得性肠球菌属细菌感染的分布特征及耐药性分析 被引量:2

DISTRIBUTION CHARACTERISTICS AND DRUG RESISTANCE OF HOSPITAL-ACQUIRED INFECTIONS DUE TO ENTEROCOCCUS SPP.
下载PDF
导出
摘要 目的:了解医院获得性肠球菌属细菌感染的分布及耐药特点,为临床治疗提供依据。方法:回顾性分析中国人民解放军总医院2013年1月至2015年12月医院获得性肠球菌属细菌感染患者的临床资料。结果:共分离肠球菌属细菌883株。细菌来源科室主要为ICU(292株,33.07%)和肝胆外科(125株,14.16%);标本分布以尿液最多见(347株,39.30%),其次为体液(315株,35.67%)和血标本(202株,22.88%);分离的肠球菌属细菌中屎肠球菌数目最多(596株,67.50%),其次为粪肠球菌(244株,27.63%)。屎肠球菌对氨苄西林、青霉素、链霉素、四环素、红霉素、万古霉素和环丙沙星的耐药率均高于粪肠球菌(P<0.05)。结论:医院获得性肠球菌属细菌感染以屎肠球菌和粪肠球菌为主,屎肠球菌具有更高的耐药率,临床治疗需依据药敏结果合理选用抗菌药物。 Objective: To characterize the clinical distribution and drug resistance of hospital-acquired infections due to Enterococcus spp and provide basis for clinical treatment. Methods: The clinical data of hospital-acquired enterococcus infection patients from 2013.1 to 2015.12 in Chinese PLA General Hospital were retrospectively analyzed. Results: A total of 883 strains of Enterococci were isolated in this study. Most of them were isolated from ICU(292 strains, 33.07%) and hepatobiliary surgery department(125 strains, 14.16%); Urine was the most common sources of these strains(347, 39.30%), followed by body fluids(315, 35.67%) and blood samples(202, 22.88%); The top organism was Enterococcus faecium(596, 67.50%), followed by Enterococcus faecalis(244, 27.63%). The resistance rates of Enterococcus faecium to ampicillin, penicillin, streptomycin, tetracycline, erythromycin, vancomycin and ciprofloxacin were obviously higher than Enterococcus faecalis(P〈0.05). Conclusions: Enterococcus faecium and Enterococcus faecalis are the main pathogens in hospitalacquired enterococcus infection, and Enterococcus faecalis has higher resistance rate. It's necessary to choose the appropriate antibiotics according to drug susceptibility test in clinical treatment.
出处 《承德医学院学报》 2018年第2期101-104,共4页 Journal of Chengde Medical University
关键词 肠球菌属 临床分布 耐药性 Enterococcus spp. Clinical distribution Drug resistance
  • 相关文献

参考文献6

二级参考文献45

  • 1National Committee for Clinical Laboratory Standard, 2002. Performance standards for antimicrobial susceptibility testing. Wayne.Pennsylvania:NCCLS, 2002.1- 50.
  • 2Jeijaszewicz J, Mlynarczyk G, Mlynarcqyk A. Antibiotic resistance in Gram-positive cocci. Int J Antimicrob Chemother, 2000,16:473-478.
  • 3Mutnick AH, Biedenbach DJ, Turnidge JD, et al. Spectrum and potency evaluation of a new oxazolidinone, linezolid:report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Diagn Microbiol Infect Dis, 2002,43:65-73.
  • 4Jones RN, Biedenbach DJ,Beach ML.Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001):report from the SENTRY Antimicrobial Surveillance Program. Diag Microbiol Infect Dis, 2003,46:77-80.
  • 5Biedenbach DJ, Stephen JM ,Jones RN. Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp.collected in the SENTRY Antimicrobial Surveillance Program-North America, 2001. Diag Microbiol Infect Dis, 2003,46:291-294.
  • 6Biedenbach DJ, Jones RN. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones:prevalence results from the SENTRY Antimicrobial Surveillance Program. Diag Microbiol Infect Dis, 2003,46:55-61.
  • 7Avanzini C, Bosio K, Volpe G, et al. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998:Survey of macrolide resistance and trend of genotype by RAPD. Microbial Drug Resistance, 2000,6:289-295.
  • 8Mutnick AH, Biedenbach DJ, Jones RN. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diag Microbiol Infect Dis, 2003,46:63-68.
  • 9张媛,张鹏,吴尚为.耐万古霉素肠球菌耐药机制及实验室检测的研究进展[J].中华医院感染学杂志,2007,17(9):1178-1180. 被引量:27
  • 10Clinical and Laboratory Standards Institute.Performance Stand-ards for Antimicrobial Susceptibility test[S].M100-S18.CLSI,2008.

共引文献1036

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部